BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li B, Liao Z, Mo Y, Zhao W, Zhou X, Xiao X, Cui W, Feng G, Zhong S, Liang Y, Du C, Huang G, Li P, Xiao X, Zhou X, Wang R, Zhang Z. Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention. Br J Cancer 2020;122:102-10. [PMID: 31819181 DOI: 10.1038/s41416-019-0638-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Harris AL. Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy. Br J Cancer 2020;122:1-3. [PMID: 31819198 DOI: 10.1038/s41416-019-0666-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
2 Li HL, Deng NH, Xiao JX, He XS. Cross-link between ferroptosis and nasopharyngeal carcinoma: New approach to radiotherapy sensitization. Oncol Lett 2021;22:770. [PMID: 34589149 DOI: 10.3892/ol.2021.13031] [Reference Citation Analysis]
3 Zhong X, Yang Y, Li B, Liang P, Huang Y, Zheng Q, Wang Y, Xiao X, Mo Y, Zhang Z, Zhou X, Huang G, Zhao W. Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism. Front Oncol 2021;11:780410. [PMID: 35047398 DOI: 10.3389/fonc.2021.780410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lu Y, Zhou X, Zhao W, Liao Z, Li B, Han P, Yang Y, Zhong X, Mo Y, Li P, Huang G, Xiao X, Zhang Z, Zhou X. Epigenetic Inactivation of Acetyl-CoA Acetyltransferase 1 Promotes the Proliferation and Metastasis in Nasopharyngeal Carcinoma by Blocking Ketogenesis. Front Oncol 2021;11:667673. [PMID: 34485115 DOI: 10.3389/fonc.2021.667673] [Reference Citation Analysis]
5 Huang H, Li S, Tang Q, Zhu G. Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma. Front Immunol 2021;12:680955. [PMID: 34566954 DOI: 10.3389/fimmu.2021.680955] [Reference Citation Analysis]